FDA Seeks Comments on Regulatory Requirements for Center for Drug Evaluation and Research

Summary

The Food and Drug Administration (FDA) is soliciting feedback from interested parties to review and potentially modify regulations related to the Center for Drug Evaluation and Research (CDER), in an effort to reduce regulatory burden while maintaining public health and statutory obligations.